C. Coronado Erdmann

Impact of Gastric Emptying on Levodopa Pharmacokinetics in Parkinson Disease Patients

Thomas M ller, C. Coronado Erdmann, Dirk Bremen et al. · Clinical Neuropharmacology · 2006 · 131 citations

Medicine, Pharmacokinetics, Pharmacology +17

LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC

Tina Cascone, Mark M. Awad, J.D. Spicer et al. · Annals of Oncology · 2023 · 100 citations · Full text

Medicine, Oncology, Pharmacology +12

Inhibition of catechol‐<i>O</i>‐methyltransferase contributes to more stable levodopa plasma levels

Thomas Müller, C. Coronado Erdmann, Siegfried Muhlack et al. · Movement Disorders · 2005 · 54 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson’s disease

Thomas Müller, C. Coronado Erdmann, Siegfried Muhlack et al. · Journal of Neural Transmission · 2006 · 53 citations

Medicine, Pharmacokinetics, Pharmacology +14

PL02.08 Perioperative vs Neoadjuvant Nivolumab for Resectable NSCLC: Patient-Level Data Analysis of CheckMate 77T vs CheckMate 816

Patrick M. Forde, Solange Peters, J. Donington et al. · Journal of Thoracic Oncology · 2024 · 48 citations

Medicine, Oncology, Surgery +10